PAYX insider files Form 4: 725 RSUs and 3,061 options at $127.52

Rhea-AI Filing Summary

Paychex (PAYX) disclosed a director’s equity awards on Form 4. The reporting person acquired 725 shares of common stock at $0, noted as restricted stock units subject to vesting. The filing also reports a new stock option grant for 3,061 shares at $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Following the transaction, 3,951 shares of common stock were beneficially owned directly.

Insider Trade Summary

7 transactions reported

Mixed 7 txns

Insider Price Kevin A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	3,061	$127.52	$390K
Grant/Award	Common Stock	725	$0.00	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 3,061 shares (Direct); Common Stock — 3,951 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Price Kevin A

(Last) (First) (Middle)

911 PANORAMA TRAIL SOUTH

(Street)

ROCHESTER NY 14625

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		A		725(1)	A	$0	3,951	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$127.52	10/15/2025		A		3,061		10/15/2026	10/14/2035	Common Stock	3,061	$127.52	3,061	D
Stock Option	$112.67							07/15/2022	07/14/2031	Common Stock	5,075		5,075	D
Stock Option	$115							07/15/2023	07/14/2032	Common Stock	3,027		3,027	D
Stock Option	$120.86							07/15/2024	07/14/2033	Common Stock	3,382		3,382	D
Stock Option	$121.63							07/15/2025	07/14/2034	Common Stock	3,351		3,351	D
Stock Option	$140.68							07/15/2026	07/14/2035	Common Stock	670		670	D

Explanation of Responses:

1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

	Prabha S. Bhandari, Attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paychex (PAYX) disclose in this Form 4?

A director reported acquiring 725 shares at $0 (restricted stock units) and receiving a stock option grant for 3,061 shares at $127.52 on 10/15/2025.

How many shares does the reporting person own after the transaction?

The filing lists 3,951 shares of common stock beneficially owned directly after the reported transactions.

What are the key terms of the new stock option grant at PAYX?

The option covers 3,061 shares at an exercise price of $127.52, exercisable 10/15/2026, expiring 10/14/2035.

What is the nature of the 725-share acquisition?

It is an award of restricted stock units, subject to vesting, under the Amended and Restated 2002 Stock Incentive Plan.

Does the filing reference Rule 10b5-1?

It includes a checkbox to indicate if trades were under a Rule 10b5‑1 plan, but the excerpt does not mark it as selected.

Are other outstanding PAYX options listed for this insider?

Yes, previously granted options are shown with strikes of $112.67, $115, $120.86, $121.63, and $140.68 and future exercisability/expirations.